Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-23

Clinical Trial Update: Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing lidocaine injections versus sham needling for whiplash-associated disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Whiplash Injuries, Neck Pain | Phase 4 | Status: WITHDRAWN